Have Fun and Enjoy it Together at the Joint JSOPMB/CTS Conference

First of all, I would like to inform Cell Transplantation
Liver tissue engineering is a big challenge in the field of cell transplantation. Seven articles focus on liverreaders that we successfully held the first joint conference of the Japan Society for Organ Preservation and targeted regenerative medicine. These ranged from the culturing of hepatocytes in the presence of polydimethMedical Biology (JSOPMB) and Cell Transplantation Society (CTS) on April 20-21, 2009, in Okayama, Japan. ylsiloxane membranes to how sheet engineering technologies can regulate the cell shape. Hepatocytes were also As the President of this memorable joint conference, I am thankful from the bottom of my heart that many cultured using a spheroid culture system, or were propagated in mouse livers, with one study confirming the genresearchers from all over the world came to Okayama to participate in this joint conference. I believe that this is an eration of coagulation and anticoagulation factors and another study demonstrating repopulation under p21-important step for us, getting together with CTS members.
Cell transplantation is one of the most important medimediated cell conditions. The final liver-related study assessed the contribution of matrix metalloproteinase-9 to cal fields in the JSOPMB, because this form of therapy can be useful for a wide range of diseases. Addressing homing of transplanted bone marrow-derived cells. Cell therapy is a big concern in diabetes treatment. the current problem of the severe human donor organ shortage for cell therapies is a big challenge.
To achieve a better outcome following islet transplantation is one of the important issues in humans. Therefore, Studies on adult and embryonic stem cells and artificial cell development, in addition to the recent and rap-12 articles relate to islet transplantation. Six of them focus on the methods available for islet isolation, includidly evolving invention of induced pluripotent stem (iPS) cells, encourages us to answer the problems coning different aspects of tissue digestion, purification, and preservation of islets. The remaining studies look at diffronting cell transplantation. Thus, the JSOPMB has now importantly focused on regenerative medicine in ferent aspects of transplantation, including the effectiveness of fresh islets for transplantation, whether collaboration with cell biologists.
One of the essential missions of the annual meeting immunoisolation of islets by macroencapsulation is beneficial for transplantation, and whether mizoribine is of the JSOPMB is to exchange new research results and create new therapeutic concepts. The JSOPMB always useful as the sole immunosuppressive agent for islet xenotransplantation. Another study reports on the adverse encourages and motivates young researchers. In this aspect, the joint conference of JSOPMB with CTS was events experienced following islet transplantation at their institution, while another study reports on a method extremely meaningful for young investigators as well as senior researchers.
to isolate islets from chronic pancreatitis patients prior to transplantation. The final study looks at the relationExcellent presentations, a total of 29, performed at the 36th annual meeting of JSOPMB (the first joint ship between islet isolation and kidney transplantation from the same non-heart-beating donor. meeting of JSOPMB with CTS) in Okayama under the supervision of Dr. N. Kobayashi (Assistant Professor, Two further studies also look at the kidneys, including one that determined whether the pharmacodynamics Department of Surgery, Okayama University Hospital, Okayama, Japan) were selected and given an opportuof the immunosuppressant tacrolimus were altered in kidney transplant patients also treated with basiliximab nity to be published.
Twenty-seven of these presentations are featured in (an antibody to the interleukin-2 receptor on T cells) as well as the beneficial effects of carbamylated erythrothis special JSOPMB issue of Cell Transplantation, one presentation has already been featured in Cell Medicine:
poietin against cyclosporine-induced nephropathy. The ability of mesenchymal stem cells following short (conPart B of Cell Transplantation, and one will be published in Cell Medicine: Part B of Cell Transplantation, ventional) but not long-term (cloned) culturing to suppress graft-versus-host disease was explored in the lymph which is a sister journal of Cell Transplantation.
There were two reviews on liver-targeted regeneranode-transplanted rat, while the ability of osteogenically differentiated mouse iPS cells to repair bone is explored tive medicine. One of them is focused on differentiation of iPS cells to hepatocytes (7) and has already been pubin another report. An additional study, which will be published in Cell Medicine, looks at whether bone lished in Cell Medicine and the other appears in this special issue. marrow and peripheral blood stem cells can promote 386 KOBAYASHI revascularization in chronic peripheral arterial occlusive has enhanced the motivation of JSOPMB members as well as board members and will continue to do so in the disease. Platelet-rich plasma containing white blood cells was found to promote wound healing compared future, while encouraging young Japanese researchers to join this organization. with normal platelet rich plasma. Finally, two studies report on the preservation of rat heart cells by desiccaEditing this special issue is my last work. I have been happy to fulfill my task of editing the special JSOPMB tion and human progenitor cells by using the silk protein sericin.
issue for the past 7 years. Especially, I want to give my best regards to Dr. David Eve for his great assistance On behalf of the JSOPMB, I express my sincere appreciation to Professor Paul R. Sanberg (Department to me. of Neurosurgery and Brain Repair, College of Medicine,
